Methyl 5-formyl-1-methyl-1H-pyrrole-3-carboxylate, 500mg

oxalic acid; tert-butyl 4-hydrazinylpiperidine-1-carboxylate, 97, 5g

Ethyl [2,2':6',2''-terpyridine]-4'-carboxylate, 98%, 10g

4-(naphthalene-2-carbonyl)-8-propyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Sodium hydroxide solution 10%, extra pure, 10 l, plastic packaging.

Imidazo[1,2-a]pyridine-3-carboxylic acid, 6-[5-[(phenylsulfonyl)amino]-3-pyridinyl]-, ethyl ester, 97%, 1g

(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid, 95.0%, 250mg

2,1,3-Benzothiadiazole>99.0%(GC)10g

(S)-3-AMINO-2-FLUOROPROPAN-1-OL HCL, 95%, 250mg

1-(aminocarbonyl)-3-piperidinecarboxylic acid hydrochloride, 95.0%, 1g

1-(5-Bromo-2-fluorophenyl)ethanol, 95.0%, 250mg

2-bromo-7-fluoroquinoline, 95.0%, 1g

2-Carbamoyl-6-nitrobenzoic acid, 98%, 250mg